0 items

in your cart
$0.00

Drug Search > Denosumab

Prescription Drug Search

Strengths available for Denosumab vial:

Denosumab vial 60mg

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Denosumab:

  • Albania
  • Antigua and Barbuda
  • Aruba
  • Australia
  • Azerbaijan
  • Bahrain
  • Bermuda
  • Bolivia
  • Bosnia and Herzegovina
  • Czech Republic
  • Fiji
  • Georgia
  • Greece
  • India
  • Iran
  • Italy
  • Jamaica
  • Latvia
  • Liechtenstein
  • Moldova, Republic of
  • Monaco
  • Morocco
  • Netherlands
  • Nicaragua
  • Panama
  • Qatar
  • Saudi Arabia
  • Serbia
  • Spain
  • Switzerland
  • Taiwan
  • Thailand
  • Tunisia
  • Turkey
  • United Arab Emirates
  • United Kingdom, UK
  • United States, US
  • Uruguay
  • Uzbekistan
  • Vanuatu
View All Countries

Latest news releases on Denosumab:

Osteoporosis Drug Market- Global And China Market Analysis - PR-USA.net

Amgen’s Denosumab is the recent entrant to the Osteoporosis treatment market, following its approval from the U.S. and European Union (also approved for bone loss associated with prostate cancer). Denosumab is expected to compete directly with the ...

Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015) - Yahoo Finance

Amgen's Denosumab is the recent entrant to the Osteoporosis treatment market, following its approval from the U.S. and European Union (also approved for bone loss associated with prostate cancer). Denosumab is expected to compete directly with ...

Amgen Presents Oncology Data - Analyst Blog - Boston Globe

In addition to presenting data on blinatumomab and rilotumumab, Amgen will present data on talimogene laherparepvec (T-VEC), AMG 386 as well as denosumab among others.

Amgen Presents Oncology Data - Zacks.com

The company intends to present results on 12 molecules from its oncology portfolio. In addition to presenting data on blinatumomab and rilotumumab, Amgen will present data on talimogene laherparepvec (T-VEC), AMG 386 as well as denosumab among others.

New cancer drugs given approval - Sunderland Echo

Of the drugs, Rituximab, which treats cancer of the blood, is being funded through primary care trust budgets with the others – Vemurafenib, Denosumab, Eribulin and Bevacizumab (Avastin) – being paid for by the cancer drug fund allocation from the Government.

Prolia May Lead to Adverse Skin Side Effects - cisionwire.com

More than 40 serious adverse effects on the skin have been linked to the osteoporosis drug Prolia (denosumab), according to a review of Food and Drug Administration records by investigators. The records include people experiencing conditions such as skin ...

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK